Ondansetron hydrochloride and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Ondansetron hydrochloride (ondansetron hydrochloride), especially for people who are female, 40-49 old, also take Zofran, and have Tardive dyskinesia.

The phase IV clinical study analyzes which people have Atelectasis when taking Ondansetron hydrochloride. It is created by eHealthMe based on reports of 11,403 people who have side effects when taking Ondansetron hydrochloride from the FDA, and is updated regularly.

What is Ondansetron hydrochloride?

Ondansetron hydrochloride has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 11,498 Ondansetron hydrochloride users. Check the latest studies of Ondansetron hydrochloride.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,434 drugs and 1,638 conditions by eHealthMe. Check the latest studies of Atelectasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11,403 people reported to have side effects when taking Ondansetron hydrochloride.
Among them, 86 people (0.75%) have Atelectasis.

Could Ondansetron hydrochloride cause Atelectasis?

Among these 86 people:

What is the gender of people who have Atelectasis when taking Ondansetron hydrochloride? *

female: 82.28 %
male: 17.72 %

What is the age of people who have Atelectasis when taking Ondansetron hydrochloride? *

What are other drugs people take besides Ondansetron hydrochloride? *

Zofran: 33 people, 38.37%
Lorazepam: 31 people, 36.05%
Metoclopramide: 28 people, 32.56%
Paclitaxel: 27 people, 31.40%
Dexamethasone: 27 people, 31.40%
Cyclophosphamide: 27 people, 31.40%
Aprepitant: 24 people, 27.91%
Ranitidine Hydrochloride: 23 people, 26.74%
Emend: 22 people, 25.58%
Ondansetron: 17 people, 19.77%

What are other side effects people have besides Atelectasis? *

Fever: 51 people, 59.30%
Cough: 50 people, 58.14%
Dyspnea (difficult or laboured breathing): 50 people, 58.14%
Rashes (redness): 45 people, 52.33%
Fatigue (feeling of tiredness): 44 people, 51.16%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 37 people, 43.02%
Computerised Tomogram Thorax Abnormal: 29 people, 33.72%
Enlarged Heart: 23 people, 26.74%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 23 people, 26.74%
Pleural Effusion (water on the lungs): 21 people, 24.42%

What are the existing conditions these people have? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 37 people, 43.02%
Breast Cancer: 28 people, 32.56%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 23 people, 26.74%
Breast Cancer Female: 16 people, 18.60%
Pain: 4 people, 4.65%
Agitation (state of anxiety or nervous excitement): 3 people, 3.49%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 3.49%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 2 people, 2.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 2.33%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron hydrochloride and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ondansetron hydrochloride:

Ondansetron hydrochloride (11,498 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Ondansetron hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,434 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,638 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron hydrochloride (the active ingredients of Ondansetron hydrochloride) and Ondansetron hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.